Could a new implant regrow your esophagus?

NCT ID NCT05877300

Recruiting now Disease control Sponsor: Harvard Apparatus Regenerative Technology, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new implant designed to help regrow a damaged section of the esophagus in up to 10 adults. The implant uses a special scaffold combined with the patient's own stem cells. The goal is to see if it is safe and can create a new, living esophageal tube. Participants will be followed for at least 2 years after surgery.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ESOPHAGEAL DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Boerhaave syndrome esophageal disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ESOPHAGEAL DISEASES

Contacts and locations

Locations

Keck Medical Center of University of Southern California
RECRUITING

Los Angeles, California, 90033, United States
Mayo Clinic
RECRUITING

Rochester, Minnesota, 55905, United States
University of Michigan
RECRUITING

Ann Arbor, Michigan, 48109, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.